Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a topical combination drug containing coal tar, coconut oil, and salicylic acid. It is primarily used for the treatment of hyperkeratotic and scaling skin conditions such as scalp psoriasis, seborrheic dermatitis (including dandruff), and atopic dermatitis involving the scalp[1][5][8]. \n- **Coal tar** acts as an antipruritic (relieves itching), keratoplastic (normalizes skin cell growth), and has weak antiseptic properties. It helps reduce inflammation and scaling by slowing down excessive skin cell proliferation[1][6]. \n- **Salicylic acid** is a keratolytic agent that softens and removes scales by promoting desquamation of corneocytes (outermost skin cells)[2][6]. This enhances penetration of other topical treatments. \n- **Coconut oil** serves as an emollient base that moisturizes the scalp/skin, helping to reduce dryness and irritation while aiding in delivery of active ingredients[5]. \n\nThe combination may be found in ointments or lotions under various brand names. These products are available over-the-counter or by prescription depending on jurisdiction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on coal tar + coconut oil + salicylic acid.